As carcinoma in situ (CIS) theoretically has no ability to invade or metastasise, performing radical cystectomy for CIS-only disease should be curative. In this single centre review over 37 years, 1964 patients undergoing cystectomy were analysed with 52 undergoing surgery...
Introduction There has undoubtedly been a dramatic increase in the number of patients diagnosed with small renal masses in recent years [1]. The rapidly expanding use of CT has led to a large number of incidental diagnoses, but increasing longevity...
1 January 2014
| Miles Goldstraw, Eleanor Ray, Susie Longhorn, Timothy Philp, Simon Choong, Daron Smith
|
URO - Urologic Oncology
Upper tract urothelial carcinoma (UTUC) is a rare disease accounting for 5-10% of all urothelial carcinomas and has an annual incidence in Western countries of 1-2 per 100,000 [1,2]. It occurs more commonly in the pelvicalyceal system as opposed to...
The aim of the ERUS-EAUN Robotic Urology Nursing Meeting is to become the educational platform for OR nurses and RNFAs working in robot-assisted urology surgery.
This Education Day aims to provide nurses with up-to-date knowledge on bladder cancer treatments and the newest developments.
Urology nurses and cancer nurses across the UK will have the opportunity to network and share their experiences and expertise.
This event is also open to nurses who wish to extend their knowledge of bladder cancer and who may be working in other areas
of urology or cancer care.
@18:30 - 19:30 CET
Get the must-have skills in presenting research in the most effective and efficient way possible. This UROwebinar organised by the European School of Urology and the European Urology journal will provide you with helpful insights in mastering your abstract submission and presentation.
ERUS24 is Europe’s biggest event dedicated to robotic urology, a highly dynamic meeting that also offers the opportunity to meet colleagues in robotic urology from across the world
6;00pm: Attend the RSM Urology Section Presidential Address on 10 October 2025, a keynote event featuring thought leadership and strategic vision in urology.
Botulinum toxin is the first biological toxin to be licensed for use in treating human disease and since its first therapeutic use in the early 1980s for strabismus has become widely used in the fields of ophthalmology, cosmetic surgery, migraine...
This year’s theme will be Game Changers in Nephrology.
There will be seven main tracks for the 62nd ERA Congress:
Physiology, Cell Biology & Genetic Diseases
Glomerular & Tubulo-interstitial Diseases
Chronic Kidney Disease
Dialysis
Kidney Transplantation
Hypertension & Diabetes
AKI & Critical Care Nephrology